Zydus Lifesciences Limited: insider trades · India · SEBI (PIT + SAST) SEBI:zydus-lifesciences-limited IN IN · SEBI (PIT + SAST) Mcap 891.2Bn€
Discover the full insider trade history of Zydus Lifesciences Limited, a listed equity based in India. Shares are quoted on IN IN, under the supervision of SEBI (PIT + SAST). Market capitalisation: €891.2bn. The latest transaction was filed on 14 November 2025 — Purchase. Among the most active insiders: DEVAL DHIRAJBHAI SHAH. Every trade is accessible without an account.
Financial data FY ended March 2025 · cache
Income statement
Revenue 225.74 Bn€
Gross profit 159.07 Bn€ 70% margin
Net income 45.26 Bn€ 20.0% margin
Balance sheet & cash
Market cap 891.22 Bn€
Total debt 32.13 Bn€
Free Cash Flow 50.64 Bn€
Last declaration on 14 November 2025
Declarations 79 total
Executives ● Purchase0 SEBI
€9,392 1,000 shares @ €9.3924
Equity Shares
SEBI:e4c9983cad445dddcd36a51c902c60061dd60bfb · 12 Nov 2025
Ideal exit: 9 Aug 2026 (T+270) Executives ● Sale0 SEBI
€3,258 292 shares @ €11.1566
Equity Shares
SEBI:f084c5e1280a5f936e24a6a81bbe585ac7c99387 · 28 Mar 2024
Executives ● Sale0 SEBI
€111,570 10,000 shares @ €11.157
Equity Shares
SEBI:b3facb9aefbc9b7ac34b3ca33b4b8fe8326744a5 · 28 Mar 2024
Executives ● Sale0 SEBI
€336,021 30,000 shares @ €11.2007
Equity Shares
SEBI:cfcaf3f423b2b28861434fae2f825a0e396ebe63 · 28 Mar 2024
Executives ● Pledge0 SEBI
€3,253 292 shares @ €11.1412
Equity Shares
SEBI:0d1f28d530aa236354476c964eeeeeb666957d3a · 28 Mar 2024
Executives ● Sale0 SEBI
€197,241 17,534 shares @ €11.249
Equity Shares
SEBI:e2c1f18ea620ac19daed7747cac15ffa1b8597a9 · 27 Mar 2024
Executives ● Sale0 SEBI
€6m 565,466 shares @ €11.1749
Equity Shares
SEBI:5c22120f18b9f1c212a3253d90cb63012e1a4f03 · 27 Mar 2024
Executives ● Sale0 SEBI
€11,149 1,000 shares @ €11.1493
Equity Shares
SEBI:6cc46fa0dbaa4d39a66c9758dbed6dcd103b5497 · 26 Mar 2024
Executives ● Sale0 SEBI
€5,445 500 shares @ €10.8905
Equity Shares
SEBI:cd3a6bd8cb6007d3435a8f5ad033858462c6327c · 22 Mar 2024
Executives ● Sale0 SEBI
€1,675 150 shares @ €11.1697
Equity Shares
SEBI:7efa676e2a258a2991aa7c30e295d438648660f7 · 26 Mar 2024
Executives ● Pledge0 SEBI
€5,522 500 shares @ €11.0445
Equity Shares
SEBI:0d176f9aa7404b01db0f581bd9a54b4c101916d7 · 22 Mar 2024
Executives ● Pledge0 SEBI
€10,404 942 shares @ €11.0445
Equity Shares
SEBI:715fc80b346f4b97dd6588a5093fd8bfba9618f3 · 22 Mar 2024
Executives ● Pledge0 SEBI
€1,687 150 shares @ €11.249
Equity Shares
SEBI:e61986bce1b5b0ff9a5cd87b88e1fe07e0dfa688 · 26 Mar 2024
Executives ● Sale0 SEBI
€9,223 862 shares @ €10.6992
Equity Shares
SEBI:b5ed393a19bf54c74e1b47ce5757430b2f3c3788 · 20 Mar 2024
Executives ● Sale0 SEBI
€841 76 shares @ €11.0661
Equity Shares
SEBI:0c481d49f86abff7255b05e0ae9c3d2858fe2982 · 14 Mar 2024
Executives ● Sale0 SEBI
€43m 3,852,363 shares @ €11.0661
Equity Shares
SEBI:68c7f0e6cd587d8285012be3973f402f8742b7d7 · 14 Mar 2024
Executives ● Sale0 SEBI
€1,671 151 shares @ €11.0661
Equity Shares
SEBI:770b4e99f8857d44d2d995f270a67bdb5869f6e0 · 14 Mar 2024
Executives ● Sale0 SEBI
€8,842 799 shares @ €11.0661
Equity Shares
SEBI:baae34f999f5abca19033d4ef26667d92e9c41c1 · 14 Mar 2024
Executives ● Sale0 SEBI
€5,090 460 shares @ €11.0661
Equity Shares
SEBI:6b91ee03f9c62c9856f384bcfa1cddf4d95a5f47 · 14 Mar 2024
Executives ● Sale0 SEBI
€112,265 10,145 shares @ €11.0661
Equity Shares
SEBI:1c2535ce27e3334a8ec2063cec3b319c9a3aefb2 · 14 Mar 2024
Executives ● Sale0 SEBI
€21,313 1,926 shares @ €11.0661
Equity Shares
SEBI:5845b83c30547b92130db56e41b53f987e3fc3bb · 14 Mar 2024
Executives ● Sale0 SEBI
€17,993 1,626 shares @ €11.0661
Equity Shares
SEBI:75e0d3cf7589340b1d90a40b9661f70270a85947 · 14 Mar 2024
Executives ● Sale0 SEBI
€841 76 shares @ €11.0661
Equity Shares
SEBI:60a15696df58dfe802528aeda95c1499301783e1 · 14 Mar 2024
Executives ● Sale0 SEBI
€841 76 shares @ €11.0661
Equity Shares
SEBI:78b3a98a419bbfb1d0828c7a578df300fc9be848 · 14 Mar 2024
Executives ● Sale0 SEBI
€841 76 shares @ €11.0661
Equity Shares
SEBI:63be9561da61ed3ff18f80ac9dd6cc76551268ab · 14 Mar 2024
25 of 79 declarations
Load more (54 remaining)